Anbio Biotechnology Ltd(NNNN:US)
Market Cap$137.38M
Key Metrics
Price$3.13
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$7.77M
Total Assets$30.24M
Net Assets$30.16M
Total Debt$0
Key Metrics
Price$3.13
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$7.77M
Total Assets$30.24M
Net Assets$30.16M
Total Debt$0
Financials
| Name |
|---|
Revenue |
Cost of Revenue |
Gross Profit |
| Research and Development |
| Selling, General, and Administrative |
| Other Operating Expenses |
Operating Income |
| Non-Operating Interest Income |
| Non-Operating Interest Expense |
| Other Income/Expense |
Income Before Tax |
Income Tax |
Net Income |
Minority Interests |
Preferred Stock Dividends |
Net Income to Common |
Shares Outstanding (Basic) |
Shares Outstanding (Diluted) |
EPS (Basic) |
EPS (Diluted) |
EBIT |
EBITDA |